Glycosaminoglycans mediate cell surface oligomerization of chemokines.

PubWeight™: 2.87‹?› | Rank: Top 1%

🔗 View Article (PMID 9354625)

Published in Biochemistry on November 04, 1997

Authors

A J Hoogewerf1, G S Kuschert, A E Proudfoot, F Borlat, I Clark-Lewis, C A Power, T N Wells

Author Affiliations

1: Department of Chemistry, University of York, Heslington, England. arlene@oligos.com

Articles citing this

(truncated to the top 100)

Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04

Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc Natl Acad Sci U S A (2003) 3.77

Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med (2000) 3.63

The endothelial glycocalyx: composition, functions, and visualization. Pflugers Arch (2007) 3.31

Regulation of CXCR4 signaling. Biochim Biophys Acta (2006) 3.16

Interconversion between two unrelated protein folds in the lymphotactin native state. Proc Natl Acad Sci U S A (2008) 2.17

Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene (2010) 1.69

HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A (1998) 1.67

Structural diversity of heparan sulfate binding domains in chemokines. Proc Natl Acad Sci U S A (2002) 1.61

Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins. Int J Cell Biol (2012) 1.58

The monomer-dimer equilibrium of stromal cell-derived factor-1 (CXCL 12) is altered by pH, phosphate, sulfate, and heparin. Protein Sci (2005) 1.57

Endocytosis and recycling of the HIV coreceptor CCR5. J Cell Biol (2000) 1.56

Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev (2007) 1.49

The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity. J Virol (1999) 1.47

Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. Proc Natl Acad Sci U S A (2004) 1.46

Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion. J Virol (1999) 1.42

The blood-brain barrier, chemokines and multiple sclerosis. Biochim Biophys Acta (2010) 1.40

Therapeutic targeting of chemokine interactions in atherosclerosis. Nat Rev Drug Discov (2010) 1.38

Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function. Exp Cell Res (2011) 1.35

Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment. PLoS One (2010) 1.29

Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity. Biosci Rep (2006) 1.26

M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS One (2011) 1.24

The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment. J Leukoc Biol (2011) 1.24

Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol (2010) 1.23

Shear-dependent eosinophil transmigration on interleukin 4-stimulated endothelial cells: a role for endothelium-associated eotaxin-3. J Exp Med (2001) 1.22

Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule 1 which mediates arrest: an early step in the process of emigration. J Exp Med (2001) 1.20

Chemokine-directed strategies to attenuate allograft rejection. Clin Lab Med (2008) 1.16

The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine (2008) 1.16

CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res (2008) 1.15

Monomeric structure of the cardioprotective chemokine SDF-1/CXCL12. Protein Sci (2009) 1.13

A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities. J Virol (2007) 1.12

Monomeric solution structure of the prototypical 'C' chemokine lymphotactin. Biochemistry (2001) 1.11

Chemokines: established and novel targets in atherosclerosis. EMBO Mol Med (2011) 1.10

An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J Leukoc Biol (2008) 1.07

Increased expression of the chemokines CXCL1 and MIP-1α by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J Neuroinflammation (2011) 1.06

Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. Structure (2011) 1.05

Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. Br J Cancer (2007) 1.03

CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B. Immunology (2009) 1.02

The C terminus of mouse monocyte chemoattractant protein 1 (MCP1) mediates MCP1 dimerization while blocking its chemotactic potency. J Biol Chem (2010) 1.02

Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci (2013) 1.02

A new monoclonal antibody, mAb 4A12, identifies a role for the glycosaminoglycan (GAG) binding domain of RANTES in the antiviral effect against HIV-1 and intracellular Ca2+ signaling. J Exp Med (1998) 1.01

Rational design of novel HIV-1 entry inhibitors by RANTES engineering. Vaccine (2008) 0.99

HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc Natl Acad Sci U S A (2008) 0.98

Engineering chemoattractant gradients using chemokine-releasing polysaccharide microspheres. Biomaterials (2011) 0.97

Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer. J Biol Chem (2013) 0.97

Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican. Neuroscience (2009) 0.96

Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies. Immunol Cell Biol (2015) 0.94

Chemokines and microRNAs in atherosclerosis. Cell Mol Life Sci (2015) 0.94

Hexuronic acid stereochemistry determination in chondroitin sulfate glycosaminoglycan oligosaccharides by electron detachment dissociation. J Am Soc Mass Spectrom (2012) 0.93

Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors. J Biol Chem (2010) 0.93

Development of a novel chemokine-mediated in vivo T cell recruitment assay. J Immunol Methods (2008) 0.92

Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion. Am J Pathol (2007) 0.92

NMR analysis of the structure, dynamics, and unique oligomerization properties of the chemokine CCL27. J Biol Chem (2010) 0.92

Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions. Biochem J (2015) 0.92

Molecular genetic analysis of orf virus: a poxvirus that has adapted to skin. Viruses (2015) 0.91

The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells. Exp Cell Res (2008) 0.91

The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization. Glycobiology (2015) 0.91

Structure of mouse IP-10, a chemokine. Acta Crystallogr D Biol Crystallogr (2008) 0.90

A model of GAG/MIP-2/CXCR2 interfaces and its functional effects. Biochemistry (2012) 0.89

Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity. Front Immunol (2013) 0.89

Analysis of an orf virus chemokine-binding protein: Shifting ligand specificities among a family of poxvirus viroceptors. Proc Natl Acad Sci U S A (2003) 0.89

The solution structure of the anti-HIV chemokine vMIP-II. Protein Sci (1999) 0.88

Effects of temperature and salt concentration on the structural stability of human lymphotactin: insights from molecular simulations. J Am Chem Soc (2006) 0.88

Therapeutically targeting protein-glycan interactions. Br J Pharmacol (2009) 0.88

Migration of antigen-specific T cells away from CXCR4-binding human immunodeficiency virus type 1 gp120. J Virol (2004) 0.88

Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun (2002) 0.88

Interaction of the CC-chemokine RANTES with glycosaminoglycans activates a p44/p42 mitogen-activated protein kinase-dependent signaling pathway and enhances human immunodeficiency virus type 1 infectivity. J Virol (2002) 0.88

Heparanase overexpression impairs inflammatory response and macrophage-mediated clearance of amyloid-β in murine brain. Acta Neuropathol (2012) 0.88

The glycocalyx-linking albuminuria with renal and cardiovascular disease. Nat Rev Nephrol (2015) 0.88

A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods. Exp Cell Res (2009) 0.87

Human macrophage inflammatory protein 3alpha: protein and peptide nuclear magnetic resonance solution structures, dimerization, dynamics, and anti-infective properties. Antimicrob Agents Chemother (2007) 0.87

The Anti-inflammatory Protein TSG-6 Regulates Chemokine Function by Inhibiting Chemokine/Glycosaminoglycan Interactions. J Biol Chem (2016) 0.87

Visualization of chemokine binding sites on human brain microvessels. J Cell Biol (1999) 0.87

Nanomechanics and sodium permeability of endothelial surface layer modulated by hawthorn extract WS 1442. PLoS One (2012) 0.87

Structural and functional studies of the potent anti-HIV chemokine variant P2-RANTES. Proteins (2010) 0.86

Soluble mimics of a chemokine receptor: chemokine binding by receptor elements juxtaposed on a soluble scaffold. Protein Sci (2003) 0.85

Functional aspects of the interaction between interleukin-8 and sulfated glycosaminoglycans. Biomatter (2013) 0.85

Polysialic acid on neuropilin-2 is exclusively synthesized by the polysialyltransferase ST8SiaIV and attached to mucin-type o-glycans located between the b2 and c domain. J Biol Chem (2013) 0.84

Role of intramolecular disulfides in stability and structure of a noncovalent homodimer. Biophys J (2007) 0.84

Primary human alveolar epithelial cells can elicit the transendothelial migration of CD14+ monocytes and CD3+ lymphocytes. Immunology (2001) 0.84

Chemokine oligomerization in cell signaling and migration. Prog Mol Biol Transl Sci (2013) 0.83

Cell surface heparan sulfate participates in CXCL1-induced signaling. Biochemistry (2003) 0.83

Novel process of intrathymic tumor-immune tolerance through CCR2-mediated recruitment of Sirpα+ dendritic cells: a murine model. PLoS One (2012) 0.82

Chemokine receptor oligomerization and allostery. Prog Mol Biol Transl Sci (2013) 0.82

A chemokine self-presentation mechanism involving formation of endothelial surface microstructures. J Immunol (2013) 0.82

An Ion Mobility-Mass Spectrometry Investigation of Monocyte Chemoattractant Protein-1. Int J Mass Spectrom (2009) 0.81

Modulation of Chemokine Responses: Synergy and Cooperativity. Front Immunol (2016) 0.81

Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop. Arthritis Res Ther (2013) 0.81

Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. Br J Pharmacol (2012) 0.81

Mouse MCP1 C-terminus inhibits human MCP1-induced chemotaxis and BBB compromise. J Neurochem (2011) 0.80

Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer. Biochemistry (2016) 0.80

Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans. Biochemistry (2010) 0.80

Chemokine CXCL1 mediated neutrophil recruitment: Role of glycosaminoglycan interactions. Sci Rep (2016) 0.80

Chemokine cooperativity is caused by competitive glycosaminoglycan binding. J Immunol (2014) 0.79

Chemokines and Glycosaminoglycans. Front Immunol (2015) 0.79

Chemokine Transfer by Liver Sinusoidal Endothelial Cells Contributes to the Recruitment of CD4+ T Cells into the Murine Liver. PLoS One (2015) 0.79

Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells. Sci Rep (2015) 0.79

Regulation of CCR5 expression in human placenta: insights from a study of mother-to-child transmission of HIV in Malawi. PLoS One (2010) 0.79

Molecular interaction studies of HIV-1 matrix protein p17 and heparin: identification of the heparin-binding motif of p17 as a target for the development of multitarget antagonists. J Biol Chem (2012) 0.79

Multimerization of monocyte chemoattractant protein-1 is not required for glycosaminoglycan-dependent transendothelial chemotaxis. Biochem J (2001) 0.79

Articles by these authors

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature (1996) 11.21

Synthesis of proteins by native chemical ligation. Science (1994) 10.98

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature (1996) 9.25

International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev (2000) 7.17

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52

Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36

Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell (1997) 4.44

Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J (1997) 4.04

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. Science (1997) 3.84

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science (2000) 3.75

Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J Clin Invest (1996) 3.74

Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells. J Exp Med (2001) 3.71

Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med (2000) 3.63

B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med (1998) 3.60

CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med (2001) 3.51

Inducible expression of H-2 and Ia antigens on brain cells. Nature (1984) 3.48

Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol (2001) 3.13

Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07

Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem (2001) 3.03

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness. J Exp Med (1998) 2.94

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity. J Exp Med (1998) 2.76

RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med (1997) 2.69

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science (1997) 2.58

Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett (1992) 2.57

Regulation of protein function by glycosaminoglycans--as exemplified by chemokines. Annu Rev Biochem (2005) 2.57

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist. J Biol Chem (1996) 2.56

Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol (1997) 2.51

HIV blocked by chemokine antagonist. Nature (1996) 2.50

Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci U S A (1993) 2.45

Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem (1995) 2.38

Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4. J Cell Biol (1997) 2.35

Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics (1993) 2.33

Neutrophil activation by monomeric interleukin-8. Science (1994) 2.31

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines. J Immunol (1983) 2.30

Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J (1994) 2.27

Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med (1996) 2.19

A key role for CC chemokine receptor 4 in lipopolysaccharide-induced endotoxic shock. J Exp Med (2000) 2.17

Neutrophil-activating properties of the melanoma growth-stimulatory activity. J Exp Med (1990) 2.17

The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Eur J Immunol (1998) 2.15

The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol (1997) 2.14

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med (1997) 2.10

Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors. J Exp Med (1996) 2.08

Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J Exp Med (1995) 2.07

Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol (1997) 2.02

Interleukin-8 induces neutrophil transendothelial migration. Immunology (1991) 2.01

Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol (1996) 1.99

Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med (1997) 1.97

The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci U S A (1981) 1.97

Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem J (1994) 1.94

The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes. J Biol Chem (1993) 1.92

The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem (2000) 1.86

Automated chemical synthesis of a protein growth factor for hemopoietic cells, interleukin-3. Science (1986) 1.84

Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem (1991) 1.83

Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest (1998) 1.81

CXCR4 as a functional coreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol (1998) 1.81

Multiple extracellular domains of CCR-5 contribute to human immunodeficiency virus type 1 entry and fusion. J Virol (1997) 1.75

The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem (2000) 1.73

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin. Eur J Immunol (1984) 1.73

The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology (1997) 1.72

Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (1998) 1.71

Mouse monocyte-derived chemokine is involved in airway hyperreactivity and lung inflammation. J Immunol (1999) 1.71

CD4-independent infection by HIV-2 (ROD/B): use of the 7-transmembrane receptors CXCR-4, CCR-3, and V28 for entry. Virology (1997) 1.70

Structure-activity relationships in engineered proteins: analysis of use of binding energy by linear free energy relationships. Biochemistry (1987) 1.69

HIV-1 Tat protein mimicry of chemokines. Proc Natl Acad Sci U S A (1998) 1.67

Signal transduction by CXC chemokine receptor 4. Stromal cell-derived factor 1 stimulates prolonged protein kinase B and extracellular signal-regulated kinase 2 activation in T lymphocytes. J Exp Med (2000) 1.67

A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5. Nature (1993) 1.64

Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J Biol Chem (1990) 1.64

Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development. J Exp Med (2001) 1.64

Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells. J Exp Med (1997) 1.63

Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med (1997) 1.61

Interleukin 10 increases CCR5 expression and HIV infection in human monocytes. J Exp Med (1998) 1.58

Endocytosis and recycling of the HIV coreceptor CCR5. J Cell Biol (2000) 1.56

1H NMR solution structure of an active monomeric interleukin-8. Biochemistry (1995) 1.56

The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem (1999) 1.55

Co-receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands. Immunol Rev (2000) 1.54